JANE STREET GROUP, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2023$407,915
-0.3%
146,732
-34.7%
0.00%
Q1 2023$409,056
+72.2%
224,756
+379.6%
0.00%
Q4 2022$237,581
+152.7%
46,860
+148.3%
0.00%
Q3 2022$94,000
-40.9%
18,874
-55.7%
0.00%
Q2 2022$159,000
-90.2%
42,605
-85.3%
0.00%
Q1 2022$1,630,000
+37.0%
290,306
+48.3%
0.00%
Q4 2021$1,190,000
-12.4%
195,803
+40.4%
0.00%
Q3 2021$1,359,000
-50.3%
139,458
-27.2%
0.00%
-100.0%
Q2 2021$2,734,000
-69.9%
191,448
-50.0%
0.00%
-80.0%
Q1 2021$9,085,000382,6760.01%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders